Blog | Payment Reimbursement and Managed Care
HFMA's Chad Mulvany says it is likely drug manufacturers will sue to stop the rule, and they may have several strong legal arguments that would at least delay, if not overturn the rule.
How To | Financial Sustainability
The November 2020 Financial Sustainability Report, sponsored by Kaufman Hall, explores the long-term implications for hospitals and health systems of the deferral of elective procedures at the start of the COVID-19 pandemic, and it provides...
Case Study | Financial Sustainability
A not-for-profit hospital in West Texas undertook a perioperative surgical home initiative wit a focus on caring for geriatric patients with hip fractures and demonstrate how such an initiative can improve patient access and clinical outco...

Price Transparency

How price transparency presents challenges and opportunities for healthcare providers to improve their consumerism appeal, drive value-based care and control the growth of healthcare spending.

HFMA news coverage of price transparency and its effects on healthcare finance.

Join your healthcare finance peers in our community discussion about price transparency.